Protective role of γ-aminobutyric acid against chronic renal failure in rats

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 11, 2006, Pages 1515-1525

  Sasaki, Sumiyo ^a   Yokozawa, Takako ^a   Cho, Eun Ju ^b   Oowada, Shigeru ^c   Kim, Mujo ^d  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Pusan National University   (South Korea)

^c Division of Dialysis Center   (Japan)

^d Pharma Foods International Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CATALASE; CHOLESTEROL; FIBRONECTIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIPID PEROXIDATION; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SODIUM URINE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ADMINISTRATION, ORAL; ALBUMINURIA; ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; CATALASE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; GAMMA-AMINOBUTYRIC ACID; GLUTATHIONE PEROXIDASE; HYPERCHOLESTEROLEMIA; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; ORGAN SIZE; RATS; RATS, WISTAR; SODIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URINATION;

EID: 33751201236     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.11.0013     Document Type: Article

References (62)

1. Aebi, H. (1974) Catalase. In: Bergmeyer, H. U. (ed.) Methods of enzymatic analysis. Verlag Chemie, New York, pp 673-687
2. Amenta, F., Cavallotti, C., Iacopino, L., Erdo, S. L. (1988) Autoradiographic localization of the GABAA receptor agonist [3H]-muscimol within rat kidney. Pharmacology 36: 390-395
3. Antonaccio, M. J., Snyder, D. W. (1981) Reductions in blood pressure, heart rate and renal sympathetic nervous discharge after imidazole-4-acetic acid: mediation through central γ-aminobutyric acid (GABA) receptor stimulation. J. Pharmacol. Exp. Ther. 218: 200-205
4. Antonaccio, M. J., Kerwin, L., Taylor, D. G. (1978) Reductions in blood pressure, heart rate and renal sympathetic nerve discharge in cats after the central administration of muscimol, a GABA agonist. Neuropharmacology 17: 783-791
5. Aoki, H., Furuya, Y., Endo, Y., Fujimoto, K. (2003) Effect of γ-aminobutyric acid-enriched tempeh-like fermented soybean (GABA-Tempeh) on the blood pressure of spontaneously hypertensive rats. Biosci. Biotechnol Biochem. 67: 1806-1808
6. Bell, D. S. (1991) Diabetic nephropathy: changing concepts of pathogenesis and treatment. Am. J. Med. Sci. 301: 195-200
7. Brenner, B. M. (1985) Nephron adaptation to renal injury or ablation. Am. J. Physiol. 249: F324-F337
8. Chertow, G. M., Bullard, A., Lazarus, J. M. (1996) Nutrition and the dialysis prescription. Am. J. Nephrol. 16: 79-89
9. DeFeudis, F. V. (1983) γ-Aminobutyric acid and cardiovascular function. Experientia 39: 845-849
10. Elstner, E. F., Heupel, A. (1976) Inhibition of nitrite formation from hydroxylammonium chloride. A simple assay for superoxide dismutase. Anal. Biochem. 70: 616-620
11. Erdo, S. L. (1990) Baclofen binding sites in rat kidney. Eur. J. Pharmacol. 184: 305-309
12. Fantone, J. C., Ward, P. A. (1982) Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107: 395-418
13. Fine, L. G., Trizna, W., Bourgoignie, J. J., Bricker, N. S. (1978) Functional profile of the isolated uremic nephron. Role of compensatory hypertrophy in the control of fluid reabsorption by the proximal straight tubule. J. Clin. Invest. 61: 1508-1518
14. Gillis, R. A., Yamada, K. A., DiMicco, J. A., Williford, D. J., Segal, S. A., Hamosh, P., Norman, W. P. (1984) Central γ-aminobutyric acid involvement in blood pressure control. Fed. Proc. 43: 32-38
15. Goodyer, P. R., Lancaster, G., Villeeneuve, M., Scriver, C. R. (1980) The relationship of 4-aminobutyric acid metabolism to ammonia-genesis in renal cortex. Biochim. Biophys. Acta 633: 191-200
16. Goodyer, P. R., Mills, M., Scriver, C. R. (1982) Properties of γ-aminobutyric acid synthesis by rat renal cortex. Biochim. Biophys. Acta 716: 348-357
17. Hafeman, D. G., Sunde, R. A., Hoekstra, W. G. (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104: 580-587
18. Harris, D. C., Chan, L., Schrier, R. W. (1988) Remnant kidney hypermetabolism and progression of chronic renal failure. Am. J. Physiol. 254: 267-276
19. Hauser, A. C., Hagen, W., Rehak, P. H., Buchmayer, H., Fodinger, M., Papagiannopoulos, M., Bieglmayer, C., Apsner, R., Koller, E., Ignatescu, M., Horl, W. H., Sunder-Plassmann, G. (2001) Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am. J. Kidney Dis. 37: 758-765
20. Hayakawa, K., Kimura, M., Kamata, K. (2002) Mechanism underlying γ-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur. J. Pharmacol. 438: 107-113
21. Hayakawa, K., Kimura, M., Kasaha, K., Matsumoto, K., Sansawa, H., Yamori, Y. (2004) Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Nutr. 92: 411-417
22. Hayslett, J. P., Kashgarian, M., Epstein, F. H. (1969) Mechanism of change in the excretion of sodium per nephron when renal mass is reduced. J. Clin. Invest. 48: 1002-1006
23. Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., Brenner, B. M. (1981) Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am. J. Physiol. 241: 85-93
24. Imai, E., Takenaka, M., Isaka, Y., Moriyama, T., Akagi, Y., Kakuchi, J., Fujii, Y., Ito, T., Hori, M., Horio, M., Syoji, T., Tsubakihara, Y. (2003) Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet. Clin. Exp. Nephrol. 7: 113-119
25. Ishiwata, T., Saito, T., Hasegawa, H., Yazawa, T., Kotani, Y., Otokawa, M., Aihara, Y. (2005) Changes of body temperalure and thermoregulatory responses of freely moving rats during GABAergic pharmacological stimulation to the preoptic area and anterior hypothalamus in several ambient temperatures. Brain Res. 1048: 32-40
26. Itzhaki, R. F., Gill, D. M. (1964) A micro-biuret method for estimating proteins. Anal. Biochem. 9: 401-410
27. Johnson, D., Lardy, H. (1967) Isolation of liver or kidney mitochondria. Methods Enzymol. X: 94-96
28. Jung, K., Pergande, M. (1985) Influence of cyclosporine A on the respiration of isolated rat kidney mitochondria. FEBS Lett. 183: 167-169
29. Kasiske, B. L., Velosa, J. A., Halstenson, C. E., La Belle, P., Langendorfer, A., Keane, W. F. (1990) The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. Am. J. Kidney Dis. 15: 8-15
30. Kim, C., Vaziri, N. D. (2005) Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. Kidney Int. 67:1028-1032
31. Kleinrok, Z., Matuszek, M., Jesipowicz, J., Matuszek, B., Opolski, A., Radzikowski, C. (1998) GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J. Physiol. Pharmacol. 49: 303-310
32. Kusano, H., Muso, E., Ono, T., Nogaki, F., Nomura, K., Takeda, T., Miyawaki, S., Matsumori, A., Yoshida, H., Sasayama, S. (2002) Heminephrectomy causes the progression of glomerulosclerosis and apoptosis in high IgA strain ddY mice. Nephron 92: 389-398
33. Matheson, G. K., Freed, E., Tunnicliff, G. (1986) Novel GABA analogues as hypotensive agents. Neuropharmacology 25: 1191-1195
34. Mihara, M., Uchiyama, M. (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86: 271-278
35. Minuk, G. Y. (2000) GABA and hepatocellular carcinoma. Mol. Cell Biochem. 207: 105-108
36. Monasterolo, L. A., Trumper, L., Elias, M. M. (1996) Effects of γ-aminobutyric acid agonists on the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 279: 602-607
37. Morrison, A. B. (1966) Experimental chronic renal insufficiency. Methods Achiev. Exp. Pathol. 1: 455-475
38. Naito, C., Yamanaka, T. (1978) Lipid peroxides in atherosclerotic diseases. Jpn. J. Geriatr. 15: 187-191
39. Nihei, T., Miura, Y., Yagasaki, K. (2001) Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats. Life Sci. 68: 2845-2852
40. Olson, J. L., Hostetter, T. H., Rennke, H. G., Brenner, B. M., Venkatachalam, M. A. (1982) Altered glomerular permselectivily and progressive sclerosis following extreme ablation of renal mass. Kidney Int. 22: 112-126
41. Opolski, A., Mazurkiewicz, M., Wietrzyk, J., Kleinrok, Z., Radzikowski, C. (2000) The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J. Exp. Clin. Cancer Res. 19: 383-390
42. Oyanagui, Y. (1984) Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal. Biochem. 142: 290-296
43. Paul, J. L., Man, N. K., Moatti, N., Raichvarg, D. (1991) Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis. Nephrologie 12: 4-7
44. Perry, T. L., Yong, V. W., Kish, S. J., Ito, M., Foulks, J. G., Godolphin, W. J., Sweeney, V. P. (1985) Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialysis. J. Neurochem. 45: 1043-1048
45. Petroff, O. A. (2002) GABA and glutamate in the human brain. Neuroscientist 8: 562-573
46. Platt, R., Roscoe, M. H., Smith, F. W. (1952) Experimental renal failure. Clin. Sci. 11: 217-231
47. Regeniter, A., Siede, W. H., Scholer, A., Huber, P., Frischmuth, N., Steiger, J. U. (2000) Interpreting complex urinary patterns with MDI LABLINK: a statistical evaluation. Clin. Chim. Acta 297: 261-273
48. Remuzzi, G., Ruggenenti, P., Benigni, A. (1997) Understanding the nature of renal disease progression. Kidney Int. 51: 2-15
49. Sakagishi, Y. (1968) Total protein. In: Saito, M., Kitamura, M., Niwa, M. (eds) Rinsho kagaku bunseki. Tokyo Kagaku Dojin, Tokyo, pp 115-142
50. Sanaka, T., Higuchi, C., Omata, M. (1991) Active oxygen as the progressive factor of chronic renal failure. Renal Failure 3: 73-77
51. Schrier, R. W., Harris, D. C., Chan, L., Shapiro, J. I., Caramelo, C. (1988) Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am. J. Kidney Dis. 12: 243-249
52. Sener, G., Paskaloglu, K., Satiroglu, H., Alican, I., Kacmaz, A., Sakarcan, A. (2004a) L-Carnitine ameliorates oxidative damage due to chronic renal failure in rats. J. Cardiovasc. Pharmacol. 43: 698-705
53. Sener, G., Paskaloglu, K., Toklu, H., Kapucu, C., Ayanoglu-Dulger, G., Kacmaz, A., Sakarcan, A. (2004b) Melatonin ameliorates chronic renal failure-induced oxidative organ damage in rats. J. Pineal Res. 36: 232-241
54. Slatopolsky, E., Elkan, I. O., Weerts, C., Bricker, N. S. (1968) Studies on the characteristics of the control system governing sodium excretion in uremic man. J. Clin. Invest. 47: 521-530
55. Tatsuta, M., Iishi, H., Baba, M., Nakaizumi, A., Ichii, M., Taniguchi, H. (1990) Inhibition by γ-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitroso-guanidine in Wistar rats. Cancer Res. 50: 4931-4934
56. Trizna, W., Yanagawa, N., Bar-Khayim, Y., Houston, B., Fine, L. G. (1981) Functional profile of the isolated uremic nephron. Evidence of proximal tubular memory in experimental renal disease. J. Clin. Invest. 68: 760-767
57. Trznadel, K., Pawlicki, L., Kedziora, J., Luciak, M., Blaszczyk, J., Buczynski, A. (1989) Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients. Free Radic. Biol. Med. 6: 393-397
58. Vaziri, N. D., Liang, K. (2004) ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Am. J. Physiol. Renal Physiol. 287: 1038-1043
59. Vaziri, N. D., Ni, Z., Oveisi, F., Liang, K., Pandian, R. (2002) Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39: 135-141
60. Yokozawa, T., Dong, E., Oura, H., Kashiwagi, H., Nonaka, G., Nishioka, I. (1997) Magnesium lithospermate B suppresses the increase of active oxygen in rats after subtotal nephrectomy. Nephron 75: 88-93
61. Yoshida, Y., Fogo, A., Shiraga, H., Glick, A.D., Ichikawa, I. (1988) Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int. 33: 855-867
62. Yoshida, Y., Fogo, A., Ichikawa, I. (1989) Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int. 35: 654-660